v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Licensing revenue $ 0 $ 850 $ 0 $ 850
Research and development 16,415 11,174 29,476 20,695
General and administrative 4,651 4,721 9,556 7,969
Total operating expenses 21,066 15,895 39,032 28,664
Loss from operations (21,066) (15,045) (39,032) (27,814)
Other income 1,185 1,969 2,518 3,951
Net loss $ (19,881) $ (13,076) $ (36,514) $ (23,863)
Net loss per share - basic and diluted (in dollars per share) $ (0.14) $ (0.1) $ (0.26) $ (0.17)
Basic and diluted weighted average shares outstanding (in shares) 138,282 137,589 138,259 137,098
Other comprehensive loss:        
Net loss $ (19,881) $ (13,076) $ (36,514) $ (23,863)
Unrealized loss on marketable securities 18 (1) (2) (128)
Comprehensive loss $ (19,863) $ (13,077) $ (36,516) $ (23,991)